SpyGlass Pharma, Inc. (SGP)
19.90
-0.27
(-1.34%)
USD |
NASDAQ |
May 28, 15:26
SpyGlass Pharma EPS Diluted (Quarterly) : -0.6934 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.1342 |
| IGC Pharma, Inc. | -0.0245 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.82M |
| Total Expenses (Quarterly) | 13.82M |
| Enterprise Value | 422.62M |
| Earnings Yield | -25.26% |